CTRI/2022/04/042311暂停3 期
Efficacy of BCG revaccination compared with oral chemoprophylaxis in household contacts aged 6-18 years for prevention of Tuberculosis disease – A phase III open labelled randomised control trial.
ICMRNIRT0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 暂停
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Healthy household contacts aged > 5 to 18 years
- •2. Previously vaccinated with BCG at birth or least 5 years ago - evidence of scar or documented immunisation record.
- •3. General good health – through history and baseline screening
- •4. Agrees to continue in the study for 2 years post enrollment
- •5. Children previously treated for LTBI and completed treatment at least 6 months ago - can also be included. However, they should be current HHC
排除标准
- •1.Any acute illness on recruitment day (Evaluate the child again at a later stage)
- •2.Fever =38 degree Celsius on recruitment day (Evaluate the child again at a later)
- •3.History / presence of autoimmune disease
- •4.Pregnancy – female participants > 15 years of age will have pregnancy test done after caretakers and participants informed consent
- •5.Evidence of active TB disease
- •6.On treatment for active TB disease or LTBI
- •7.HIV positive
- •8.Any history or present possible immunodeficiency condition
- •9.History of administration of immunoglobulins/immunotherapy/immune-suppressants/blood products in the preceding 3 months or planned administration during the study period
- •10.History of allergic reactions to vaccines in past
- •11.History of severe adverse reactions to primary BCG
- •12.Pre-existing liver dysfunction
- •13.ALT/AST is = 3 times upper limit of normal (ULN) in the presence of symptoms or = 5 times the ULN in the absence of symptoms and/or total bilirubin greater than ULN along with raised ALT/AST.
- •14.History of previous administration of newer/trial TB vaccines
- •15. Participation in other clinical trials in preceding 3 months or planned / concurrent participation
- •16.History of chronic renal failure, malignancy, transplants (cardiac/renal/liver), inflammatory or metabolic conditions, neurological/seizure/psychiatric disorders – issues that make participant unlikely to volunteer
研究者
相似试验
进行中(未招募)
不适用
Effect of BCG vaccination for tuberculosis on COVID-19 in BrazilCOVID-19 (SARS-CoV-2 infection) in persons who were previously given the BCG vaccineInfections and InfestationsISRCTN47802196ational Council for Scientific and Technological Development200,805
暂停
3 期
BCG Revaccination in Children and AdolescentsTuberculosis InfectionTuberculosisNCT05330884Tuberculosis Research Centre, India9,200
招募中
不适用
Protective effect of re-vaccination withBCG against COVID-19 in healthcare workers â?? A Pilot StudyCTRI/2020/09/027684SGT University
进行中(未招募)
2 期
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 YearsAutoimmune DiabetesType 1 DiabetesDiabetes MellitusDiabetes MellitusType 1 DiabetesNCT05866536Massachusetts General Hospital100
招募中
2 期
Effect of BCG in treatment of diabetes type 1IRCT20201012049003N1Yazd University of Medical Sciences16
